99-20367. Medical Devices; Global Harmonization Task Force: Summary Technical File Documents for Premarket Documentation of Conformity With Requirements for Medical Devices; Recommendations on the Role of Standards in the Assessment of Medical ...  

  • [Federal Register Volume 64, Number 152 (Monday, August 9, 1999)]
    [Notices]
    [Pages 43196-43197]
    From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
    [FR Doc No: 99-20367]
    
    
    -----------------------------------------------------------------------
    
    DEPARTMENT OF HEALTH AND HUMAN SERVICES
    
    Food and Drug Administration
    [Docket No. 99N-2359]
    
    
    Medical Devices; Global Harmonization Task Force: Summary 
    Technical File Documents for Premarket Documentation of Conformity With 
    Requirements for Medical Devices; Recommendations on the Role of 
    Standards in the Assessment of Medical Devices; and a Recommendation on 
    Medical Device Classification; Availability
    
    AGENCY: Food and Drug Administration, HHS.
    ACTION: Notice.
    
    -----------------------------------------------------------------------
    
    SUMMARY: The Food and Drug Administration (FDA) is announcing the 
    availability of three documents entitled ``Summary Technical File for 
    Premarket Documentation of Conformity With Requirements for Medical 
    Devices;'' ``Recommendation: Role of Standards in the Assessment of 
    Medical Devices;'' and ``Recommendation on Medical Devices 
    Classification.'' Study group 1 of the Global Harmonization Task Force 
    (GHTF) has prepared these documents on premarket regulation of medical 
    devices. These documents are intended to provide information only and 
    represent harmonized proposals and recommendations that may be used by 
    governments developing or updating their premarket regulation schemes 
    for medical devices. Elements of the approach set forth in these 
    documents may not be consistent with current U. S. regulatory 
    requirements. FDA is requesting comments on these documents.
    
    DATES: Written comments by September 30, 1999. After the close of the 
    comment period, written comments may be submitted at any time to Kimber 
    C. Richter (address below).
    
    ADDRESSES: Submit written comments on the documents to the Dockets 
    Management Branch (HFA-305), Food and Drug Administration, 5630 Fishers 
    Lane, rm. 1061, Rockville, MD 20852. Comments should be identified with 
    the docket number found in brackets in the heading of this document. If 
    you do not have access to the World Wide Web (WWW), submit written 
    requests for single copies on a 3.5'' diskette of the document listed 
    above to the Division of Small Manufacturers Assistance (HFZ-220), 
    Center for Devices and Radiological Health, Food and Drug 
    Administration, 1350 Piccard Dr., Rockville, MD 20850. Send two self-
    addressed adhesive labels to assist that office in processing your 
    requests, or fax your request to 301-443-8818. See the SUPPLEMENTARY 
    INFORMATION section for information on electronic access to these 
    documents.
    
    FOR FURTHER INFORMATION CONTACT: Kimber C. Richter, Office of Device 
    Evaluation (HFZ-400), Center for Devices and Radiological Health, Food 
    and Drug Administration, 9200 Corporate Blvd., Rockville, MD 20850, 
    301-594-2022.
    
    SUPPLEMENTARY INFORMATION:
    
    I. Background
    
        FDA has participated in a number of activities to promote the 
    international harmonization of regulatory requirements. In September 
    1992, a meeting was held in Nice, France, by senior regulatory 
    officials to evaluate international harmonization. At this time it was 
    decided to form GHTF to facilitate harmonization. Subsequent meetings 
    have been held on a yearly basis in various locations throughout the 
    world. The most recent GHTF meeting was held in June and July 1999, in 
    Bethesda, MD, in the United States.
        The objective of the GHTF is to encourage convergence at the global 
    level of regulatory systems of medical devices in order to facilitate 
    trade while preserving the right of participating members to address 
    the protection of public health by regulatory means considered most 
    suitable. One of the ways this objective is achieved is by identifying 
    and developing areas of international cooperation in order to 
    facilitate progressive reduction of technical and regulatory 
    differences in systems established to regulate medical devices. In an 
    effort to accomplish these objectives, the GHTF has formed four study 
    groups to draft documents and carry on other activities designed to 
    facilitate global harmonization. This notice is a result of documents 
    that have been developed by study group 1.
        Study group 1 was formed in January 1993, and was originally tasked 
    with identifying differences between various regulatory systems. In 
    1995, the group was asked to propose areas of potential harmonization 
    for premarket device regulations and possible guidance that could help 
    lead to harmonization. As a result of their efforts, this group has 
    developed three draft documents that are described briefly in the 
    following paragraphs.
        (1) ``Summary Technical File for Premarket Documentation of 
    Conformity With Requirements for Medical Devices'' (GHTF.SG1.NO11R7). 
    Study group 1 suggests that this document should be used with the 
    document
    
    [[Page 43197]]
    
    entitled ``Essential Principles of Safety and Performance of Medical 
    Devices on a Global Basis; Final Working Draft'' (63 FR 46227, August 
    31,1998).
        This document has been developed to encourage global convergence of 
    regulatory systems and provide one means of potential future 
    achievement. It is intended for use by medical device regulators, 
    conformity assessment bodies, and industry, and offers an economic and 
    effective approach to the control of medical devices in the interest of 
    public health. The document will be of value to countries developing or 
    amending regulations. The regulatory requirements of some countries may 
    not, at present, reflect the contents of this document.
        The purpose of this document is to propose a format and harmonized 
    content for a summary technical file to be held by the sponsor or 
    submitted, as required by the regulatory authority, for premarket 
    clearance/approval. It proposes a format that may be used as an 
    alternative to country-specific current submission formats by GHTF 
    member states. This document summarizes the technical information 
    needed to demonstrate conformity to premarket requirements that are 
    consistent across various regulatory systems. Users of this document 
    may submit it to various regulatory authorities with country specific 
    additions as needed. (These will be defined in a second volume still 
    under development.) Study group 1 may focus on these differences for 
    future harmonization efforts. It should be noted that the amount of 
    detail and information that will be needed in the summary technical 
    file may vary considerably with the risk class of the product 
    concerned.
        (2)``Recommendation: Role of Standards in the Assessment of Medical 
    Devices'' (GHTF.SG1.NO12R7). This GHTF document provides harmonized 
    guidance for regulatory authorities on the use of standards in 
    premarket regulation of devices. It suggests that international 
    standards may assure the safety, quality and performance of medical 
    devices and should serve as the building blocks for a harmonized 
    regulatory process. Additionally, it recommends that regulatory 
    authorities and industry should encourage and support the development 
    of international standards for medical devices to demonstrate 
    compliance with the essential principles of safety and performance of 
    medical devices. It suggests that the use of standards is voluntary, 
    except in those particular cases where the regulatory authority has 
    deemed certain standards mandatory.
        (3)``Recommendation on Medical Devices Classification.'' This GHTF 
    document suggests some general guidelines for classification of medical 
    devices to achieve eventual harmonization. It recommends that there is 
    a need to classify medical devices based on their risk to patients, 
    users and other persons; and that there is a benefit for manufacturers 
    and regulatory authorities if a globally harmonized classification 
    system is developed. This document goes on to say that there is a risk 
    presented by a particular device and that the risk depends on its 
    intended purpose and the effectiveness of the risk management 
    techniques applied during the design, manufacture, and use of that 
    device. The document also suggests that the regulatory controls applied 
    should be proportional to the level of risk associated with a medical 
    device and should increase with the associated degree of risk presented 
    by the medical device. The GHTF Study Group suggests four global 
    classifications of devices. This document also presents a Decision Tree 
    Logic that may help regulatory authorities develop different parameters 
    that might be used to classify specific devices.
        These documents are presented for review and comment so that 
    industry and other members of the public may express their views and 
    opinions on these matters.
    
    II. Electronic Access
    
        Persons interested in obtaining copies of these draft documents may 
    also do so using the WWW. Updated on a regular basis, the CDRH home 
    page includes the document entitled ``Essential Principles for Safety 
    and Performance of Medical Devices on a Global Basis; Final Working 
    Draft,'' device safety alerts, (including lists of approved 
    applications and manufacturers' addresses), small manufacturers' 
    assistance, information on video-oriented conferencing and electronic 
    submissions, mammography matters, and other device-oriented 
    information. The CDRH home page may be accessed at ``http://
    www.fda.gov/CDRH''. Information on the GHTF may be accessed at http://
    www.GHTF.org''.
    
    III. Comments
    
        Interested persons may, on or before September 30, 1999, submit to 
    the Dockets Management Branch (address above) written comments 
    regarding the draft documents. Two copies of any comments are to be 
    submitted, except that individuals may submit one copy. Comments are to 
    be identified with docket number found in brackets in the heading of 
    this document and with the full title of these documents. The draft 
    documents and received comments may be seen in the Dockets Management 
    Branch between 9 a.m. and 4 p.m., Monday through Friday.
        After September 30, 1999, written comments regarding the draft 
    documents may be submitted at any time to the contact person (address 
    above).
    
        Dated: July 25, 1999.
    Linda S. Kahan,
    Deputy Director for Regulations Policy, Center for Devices and 
    Radiological Health.
    [FR Doc. 99-20367 Filed 8-6-99; 8:45 am]
    BILLING CODE 4160-01-F
    
    
    

Document Information

Published:
08/09/1999
Department:
Food and Drug Administration
Entry Type:
Notice
Action:
Notice.
Document Number:
99-20367
Dates:
Written comments by September 30, 1999. After the close of the comment period, written comments may be submitted at any time to Kimber
Pages:
43196-43197 (2 pages)
Docket Numbers:
Docket No. 99N-2359
PDF File:
99-20367.pdf